The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells

Nature Biotechnology

Volumn 27, Issue 3, 2009, Pages 281-287

  Blum, Barak ^a   Bar Nur, Ori ^a   Golan Lev, Tamar ^a   Benvenisty, Nissim ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; APOPTOTIC; APOPTOTIC GENES; BASIC PRINCIPLES; CELL LINES; CELL THERAPIES; EMBRYOID BODIES; EMBRYONIC STEMS; GENE EXPRESSION ANALYSIS; HUMAN EMBRYONIC STEM (HES) CELL; HUMAN EMBRYONIC STEM CELLS; IN-VITRO; IN-VIVO; POLYCLONAL; SURVIVIN;

CELL CULTURE; CELL DEATH; GENE EXPRESSION;

TUMORS;

SURVIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; DIPLOIDY; EMBRYO; EMBRYONIC STEM CELL; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TERATOCARCINOMA; TERATOMA;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; TERATOMA;

EID: 62149096747     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.1527     Document Type: Article

References (35)

1. Blum, B. & Benvenisty, N. Clonal analysis of human embryonic stem cell differentiation into teratomas. Stem Cells 25, 1924-1930 (2007).
2. Blum, B. & Benvenisty, N. The tumorigenicity of human embryonic stem cells. Adv. Cancer Res. 100, 133-158 (2008).
3. Gidekel, S., Pizov, G., Bergman, Y. & Pikarsky, E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4, 361-370 (2003).
4. Oosterhuis, J.W. & Looijenga, L.H. Testicular germ-cell tumours in a broader perspective. Nat. Rev. Cancer 5, 210-222 (2005).
5. Baker, D.E. et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 25, 207-215 (2007).
6. Cowan, C.A. et al. Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 350, 1353-1356 (2004).
7. Thomson, J.A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
8. Looijenga, L.H. et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 63, 2244-2250 (2003).
9. Hart, A.H. et al. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 104, 2092-2098 (2005).
10. Martin, G.R. & Evans, M.J. The morphology and growth of a pluripotent teratocarcinoma cell line and its derivatives in tissue culture. Cell 2, 163-172 (1974).
11. Damjanov, I. & Andrews, P.W. Ultrastructural differentiation of a clonal human embryonal carcinoma cell line in vitro. Cancer Res. 43, 2190-2198 (1983).
12. Albanell, J. et al. Telomerase activity in germ cell cancers and mature teratomas. J. Natl. Cancer Inst. 91, 1321-1326 (1999).
13. Lowe, S.W., Jacks, T., Housman, D.E. & Ruley, H.E. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc. Natl. Acad. Sci. USA 91, 2026-2030 (1994).
14. Itskovitz-Eldor, J. et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 6, 88-95 (2000).
15. Diehn, M. et al. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res. 31, 219-223 (2003).
16. Li, F. et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584 (1998).
17. Ambrosini, G., Adida, C. & Altieri, D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3, 917-921 (1997).
18. Adida, C. et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am. J. Pathol. 152, 43-49 (1998).
19. Uren, A.G. et al. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr. Biol. 10, 1319-1328 (2000).
20. Grossman, D., Kim, P.J., Schechner, J.S. & Altieri, D.C. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc. Natl. Acad. Sci. USA 98, 635-640 (2001).
21. O'Connor, D.S., Wall, N.R., Porter, A.C. & Altieri, D.C. A p34(cdc2) survival checkpoint in cancer. Cancer Cell 2, 43-54 (2002).
22. Mesri, M., Wall, N.R., Li, J., Kim, R.W. & Altieri, D.C. Cancer gene therapy using a survivin mutant adenovirus. J. Clin. Invest. 108, 981-990 (2001).
23. Ma, X. et al. High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro. J. Biotechnol. 123, 367-378 (2006).
24. Walt, H., Oosterhuis, J.W. & Stevens, L.C. Experimental testicular germ cell tumorigenesis in mouse strains with and without spontaneous tumours differs from development of germ cell tumours of the adult human testis. Int. J. Androl. 16, 267-271 (1993).
25. Takahashi, K., Mitsui, K. & Yamanaka, S. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 423, 541-545 (2003).
26. Kameda, T. & Thomson, J.A. Human ERas gene has an upstream premature polyadenylation signal that results in a truncated, noncoding transcript. Stem Cells 23, 1535-1540 (2005).
27. Rangarajan, A., Hong, S.J., Gifford, A. & Weinberg, R.A. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6, 171-183 (2004).
28. Damjanov, I. & Andrews, P.W. The terminology of teratocarcinomas and teratomas. Nat. Biotechnol. 25, 1212 (2007).
29. Lensch, M.W. & Ince, T.A. The terminology of teratocarcinomas and teratomas. Nat. Biotechnol. 25, 1211 (2007).
30. Yang, D., Welm, A. & Bishop, J.M. Cell division and cell survival in the absence of survivin. Proc. Natl. Acad. Sci. USA 101, 15100-15105 (2004).
31. Goga, A., Yang, D., Tward, A.D., Morgan, D.O. & Bishop, J.M. Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC. Nat. Med. 13, 820-827 (2007).
32. Eiges, R. et al. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr. Biol. 11, 514-518 (2001).
33. Schuldiner, M., Itskovitz-Eldor, J. & Benvenisty, N. Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 21, 257-265 (2003).
34. Altieri, D.C. Survivin, cancer networks and pathway-directed drug discovery. Nat. Rev. Cancer 8, 61-70 (2008).
35. Dvash, T. et al. Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. Hum. Reprod. 19, 2875-2883 (2004).